GEP20094577B - New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it - Google Patents
New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing itInfo
- Publication number
- GEP20094577B GEP20094577B GEAP20069559A GEAP2006009559A GEP20094577B GE P20094577 B GEP20094577 B GE P20094577B GE AP20069559 A GEAP20069559 A GE AP20069559A GE AP2006009559 A GEAP2006009559 A GE AP2006009559A GE P20094577 B GEP20094577 B GE P20094577B
- Authority
- GE
- Georgia
- Prior art keywords
- pharmaceutical compositions
- crystalline form
- compositions containing
- agomelatine
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pregnancy & Childbirth (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
Crystalline form IV of the compound of the formula: which is characterized with powder X-ray diffraction diagram, method for its production and pharmaceutical compositions containing them.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0508277A FR2889522B1 (en) | 2005-08-03 | 2005-08-03 | NOVEL IV CRYSTALLINE FORM OF AGOMELATIN, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
GEP20094577B true GEP20094577B (en) | 2009-01-12 |
Family
ID=36589248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GEAP20069559A GEP20094577B (en) | 2005-08-03 | 2006-08-02 | New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP2008994A1 (en) |
JP (1) | JP4580371B2 (en) |
CN (1) | CN100445264C (en) |
AR (1) | AR057714A1 (en) |
AU (1) | AU2006203340B2 (en) |
BR (1) | BRPI0603043A (en) |
CA (1) | CA2555119A1 (en) |
CO (1) | CO5780132A1 (en) |
EA (1) | EA010867B1 (en) |
FR (1) | FR2889522B1 (en) |
GE (1) | GEP20094577B (en) |
GT (1) | GT200600345A (en) |
HK (1) | HK1098129A1 (en) |
MA (1) | MA28450B1 (en) |
MX (1) | MXPA06008693A (en) |
MY (1) | MY141306A (en) |
NO (1) | NO20063518L (en) |
NZ (1) | NZ548863A (en) |
PE (1) | PE20070242A1 (en) |
SA (1) | SA06270254B1 (en) |
SG (1) | SG130111A1 (en) |
TW (1) | TWI327564B (en) |
UA (1) | UA83718C2 (en) |
WO (1) | WO2007015002A2 (en) |
ZA (1) | ZA200606455B (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2923482B1 (en) | 2007-11-09 | 2010-01-29 | Servier Lab | NOVEL VI CRYSTALLINE FORM OF AGOMELATIN, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
FR2934856B1 (en) * | 2008-08-05 | 2010-08-13 | Servier Lab | NEW PROCESS FOR OBTAINING THE V-CRYSTALLINE FORM OF AGOMELATIN |
CN101585779B (en) * | 2009-03-10 | 2014-04-02 | 上海医药工业研究院 | New crystal form of Agomelatine, preparation method and use thereof |
WO2011006387A1 (en) * | 2009-07-11 | 2011-01-20 | 浙江华海药业股份有限公司 | Process for preparing agomelatine, crystals of agomelatine and preparing process thereof |
CN102001959B (en) * | 2009-09-01 | 2014-07-02 | 北京本草天源药物研究院 | Medicinal crystal as well as preparation method and application thereof |
CN102050755B (en) * | 2009-10-29 | 2014-11-05 | 重庆医药工业研究院有限责任公司 | Novel agomelatine crystal forms and preparation methods of agomelatine crystal forms |
CN101781226B (en) | 2009-12-23 | 2012-03-28 | 天津泰普药品科技发展有限公司 | Agomelatine and medicine composition thereof |
CN101870662B (en) * | 2010-05-21 | 2013-03-20 | 中山大学 | Crystalline Agomelatine solvate and preparation method thereof |
EP2580183B1 (en) | 2010-06-10 | 2014-07-23 | Gador S.A. | New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide |
CN102690209A (en) * | 2011-03-23 | 2012-09-26 | 上海医药工业研究院 | Mixed crystal of agomelatine (form-VIII), preparation method and application thereof and pharmaceutical composition containing the same |
CN102690210A (en) * | 2011-03-23 | 2012-09-26 | 上海医药工业研究院 | Novel crystal form VII of agomelatine, preparation method and application thereof and pharmaceutical composition containing the same |
FR2978916B1 (en) | 2011-08-10 | 2013-07-26 | Servier Lab | SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN |
CN102503886B (en) * | 2011-10-11 | 2013-09-11 | 中山大学 | Agomelatine-isonicotine eutectic crystal and compound and preparation method thereof |
WO2013082302A1 (en) | 2011-11-30 | 2013-06-06 | Ratiopharm Gmbh | Agomelatine-urea complex and crystalline forms thereof |
CZ2012108A3 (en) | 2012-02-15 | 2013-02-27 | Zentiva Ks | A method for the manufacture of a polymorphously stable pharmaceutical composition containing agomelatine |
CN102643208B (en) * | 2012-04-14 | 2013-11-06 | 中山大学 | Preparation method of agomelatine I crystal form |
WO2014096373A1 (en) | 2012-12-21 | 2014-06-26 | Laboratorios Lesvi, S. L. | Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof |
FR3001894A1 (en) | 2013-02-08 | 2014-08-15 | Servier Lab | SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN |
PL2810656T3 (en) | 2013-06-06 | 2018-01-31 | Zentiva Ks | Agomelatine formulations comprising agomelatine in the form of co-crystals |
EP2810647A1 (en) | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid |
CZ2013621A3 (en) | 2013-08-13 | 2015-02-25 | Zentiva, K.S. | Agomelatine thermodynamically stable congealed solution for use in pharmaceutical formulation |
WO2015124496A1 (en) | 2014-02-19 | 2015-08-27 | Synthon B.V. | Pharmaceutical composition comprising amorphous agomelatine |
EP3075724B1 (en) | 2015-03-31 | 2023-07-12 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Solid form of agomelatine |
EP3466413A1 (en) | 2017-10-09 | 2019-04-10 | KRKA, d.d., Novo mesto | Pharmaceutical composition containing agomelatine and process for the preparation thereof |
EP3466923A1 (en) | 2017-10-09 | 2019-04-10 | KRKA, d.d., Novo mesto | Process for the preparation of agomelatine in crystalline form |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (en) * | 1990-02-27 | 1993-12-31 | Adir Cie | NOVEL DERIVATIVES WITH NAPHTHALENIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR2866336B1 (en) * | 2004-02-13 | 2006-03-24 | Servier Lab | NOVEL PROCESS FOR THE SYNTHESIS OF (7-METHOXY-3,4-DIHYDRO-1-NAPHTHALENYL) ACETONITRILE AND APPLICATION TO THE SYNTHESIS OF AGOMELATIN |
FR2866335B1 (en) * | 2004-02-13 | 2006-05-26 | Servier Lab | NEW PROCESS FOR THE SYNTHESIS OF AGOMELATIN |
-
2005
- 2005-08-03 FR FR0508277A patent/FR2889522B1/en not_active Expired - Fee Related
-
2006
- 2006-07-19 PE PE2006000867A patent/PE20070242A1/en not_active Application Discontinuation
- 2006-07-24 MA MA29211A patent/MA28450B1/en unknown
- 2006-07-31 CO CO06074815A patent/CO5780132A1/en not_active Application Discontinuation
- 2006-07-31 GT GT200600345A patent/GT200600345A/en unknown
- 2006-08-01 NZ NZ548863A patent/NZ548863A/en not_active IP Right Cessation
- 2006-08-01 SG SG200605172-6A patent/SG130111A1/en unknown
- 2006-08-01 SA SA06270254A patent/SA06270254B1/en unknown
- 2006-08-02 EP EP08017459A patent/EP2008994A1/en not_active Withdrawn
- 2006-08-02 WO PCT/FR2006/001867 patent/WO2007015002A2/en active Application Filing
- 2006-08-02 GE GEAP20069559A patent/GEP20094577B/en unknown
- 2006-08-02 MX MXPA06008693A patent/MXPA06008693A/en active IP Right Grant
- 2006-08-02 NO NO20063518A patent/NO20063518L/en not_active Application Discontinuation
- 2006-08-02 BR BRPI0603043-2A patent/BRPI0603043A/en not_active Application Discontinuation
- 2006-08-02 EA EA200601271A patent/EA010867B1/en not_active IP Right Cessation
- 2006-08-02 MY MYPI20063734A patent/MY141306A/en unknown
- 2006-08-02 AR ARP060103365A patent/AR057714A1/en unknown
- 2006-08-02 EP EP06291252A patent/EP1752444A1/en not_active Withdrawn
- 2006-08-02 UA UAA200608687A patent/UA83718C2/en unknown
- 2006-08-02 TW TW095128301A patent/TWI327564B/en not_active IP Right Cessation
- 2006-08-03 JP JP2006211621A patent/JP4580371B2/en not_active Expired - Fee Related
- 2006-08-03 AU AU2006203340A patent/AU2006203340B2/en not_active Ceased
- 2006-08-03 CN CNB2006101083948A patent/CN100445264C/en not_active Expired - Fee Related
- 2006-08-03 CA CA002555119A patent/CA2555119A1/en not_active Abandoned
- 2006-08-03 ZA ZA200606455A patent/ZA200606455B/en unknown
-
2007
- 2007-04-30 HK HK07104584.7A patent/HK1098129A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20063518L (en) | 2007-02-05 |
FR2889522A1 (en) | 2007-02-09 |
JP4580371B2 (en) | 2010-11-10 |
JP2007051141A (en) | 2007-03-01 |
GT200600345A (en) | 2007-03-28 |
MA28450B1 (en) | 2007-03-01 |
NZ548863A (en) | 2008-03-28 |
UA83718C2 (en) | 2008-08-11 |
ZA200606455B (en) | 2007-12-27 |
WO2007015002A2 (en) | 2007-02-08 |
FR2889522B1 (en) | 2007-12-28 |
AU2006203340B2 (en) | 2012-07-19 |
EA010867B1 (en) | 2008-12-30 |
CN1907957A (en) | 2007-02-07 |
MY141306A (en) | 2010-04-16 |
AR057714A1 (en) | 2007-12-12 |
CN100445264C (en) | 2008-12-24 |
MXPA06008693A (en) | 2007-02-02 |
TWI327564B (en) | 2010-07-21 |
EP2008994A1 (en) | 2008-12-31 |
CO5780132A1 (en) | 2007-07-31 |
EP1752444A1 (en) | 2007-02-14 |
BRPI0603043A (en) | 2007-03-20 |
SA06270254B1 (en) | 2010-08-02 |
CA2555119A1 (en) | 2007-02-03 |
PE20070242A1 (en) | 2007-05-06 |
HK1098129A1 (en) | 2007-07-13 |
WO2007015002A3 (en) | 2007-04-12 |
EA200601271A1 (en) | 2007-02-27 |
SG130111A1 (en) | 2007-03-20 |
TW200736198A (en) | 2007-10-01 |
AU2006203340A1 (en) | 2007-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20094577B (en) | New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
GEP20094576B (en) | New cyrstalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
UA97478C2 (en) | Crystalline form vi of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
UA83720C2 (en) | New cyrstalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
JO2548B1 (en) | Beta Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | |
MY158127A (en) | Bd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | |
TW200640872A (en) | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | |
UA90266C2 (en) | Delta-d-crystalline form of ivabradine hydrochloride, process for its preparation and pharmaceutical composition containing it | |
MY157933A (en) | ?d-CRYSTALLINE FORM OF IVABRADINE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
UA90265C2 (en) | Delta-crystalline form ivabradine hydrochloride, process for its preparation and pharmaceutical composition containing it | |
MY143557A (en) | Beta-crystalline form of perindopril arginine salt, process for its preparation, and pharmaceutical compositions containing it | |
MY151035A (en) | ? crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it | |
GEP20094652B (en) | New cyrstalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
TNSN05076A1 (en) | New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it | |
MY138209A (en) | New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it. | |
TNSN05077A1 (en) | New y crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it | |
MY142738A (en) | Preparation method of a novel beta crystalline form of perindopril tert-butylamine salt | |
TNSN05078A1 (en) | New beta crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it |